Susquehanna International Group, LLP Oncternal Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	BUY	$3.37 - $4.76 $317,117 - $447,916	94,100 Added 282.58%	127,400 $531,000
Q2 2021 Aug 11, 2021	SELL	$4.75 - $9.39 $237,975 - $470,439	-50,100 Reduced 60.07%	33,300 $158,000
Q1 2021 May 17, 2021	BUY	$4.59 - $9.04 $261,171 - $514,375	56,900 Added 214.72%	83,400 $694,000
Q4 2020 Feb 16, 2021	BUY	$1.51 - $6.3 $40,015 - $166,950	26,500 New	26,500 $130,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.